0

    524314

    GUJTERC

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GUJARAT TERCE LABORATORIES LTD Share Price Today

    Investment Returns

    Over 1 Month 23.41% Over 3 Months 14.49% Over 6 Months -1.54% Over 1 Year -12.78%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GUJARAT TERCE LABORATORIES LTD fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 32.00
    • P/E Ratio (TTM) 14.82
    • Beta 0.66
    • Book Value / share 12.48
    • Return on equity 28.46%
    • EPS (TTM) 3.15
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.10
    info icon alternate text

    GUJARAT TERCE LABORATORIES LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 11.40
    Operating Expense 10.81
    Net Profit 0.10
    Net Profit Margin (%) 0.87
    Earnings Per Share (EPS) 0.13
    EBITDA 0.36
    Effective Tax Rate (%) 50.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 12.29
    Operating Expense 11.29
    Net Profit 0.76
    Net Profit Margin (%) 6.18
    Earnings Per Share (EPS) 0.95
    EBITDA 1.27
    Effective Tax Rate (%) 32.74
    Particulars SEP 2025 (Values in Cr)
    Revenue 12.93
    Operating Expense 11.20
    Net Profit 1.40
    Net Profit Margin (%) 10.82
    Earnings Per Share (EPS) 1.89
    EBITDA 1.95
    Effective Tax Rate (%) 21.34
    Particulars JUN 2025 (Values in Cr)
    Revenue 10.85
    Operating Expense 11.02
    Net Profit -0.04
    Net Profit Margin (%) -0.36
    Earnings Per Share (EPS) -0.06
    EBITDA 0.08
    Effective Tax Rate (%) 42.85
    Particulars MAR 2025 (Values in Cr)
    Revenue 12.32
    Operating Expense 11.44
    Net Profit -3.39
    Net Profit Margin (%) -27.51
    Earnings Per Share (EPS) -4.57
    EBITDA 1.14
    Effective Tax Rate (%) 449.48
    Particulars MAR 2026 (Values in Cr)
    Revenue 47.47
    Operating Expense 44.33
    Net Profit 2.20
    Net Profit Margin (%) 4.63
    Earnings Per Share (EPS) 2.92
    EBITDA 3.63
    Effective Tax Rate (%) 27.39
    Particulars MAR 2025 (Values in Cr)
    Revenue 50.20
    Operating Expense 47.12
    Net Profit -0.98
    Net Profit Margin (%) -1.95
    Earnings Per Share (EPS) -1.31
    EBITDA 4.19
    Effective Tax Rate (%) 128.90
    Particulars MAR 2024 (Values in Cr)
    Revenue 47.97
    Operating Expense 47.76
    Net Profit 0.24
    Net Profit Margin (%) 0.50
    Earnings Per Share (EPS) 0.33
    EBITDA 1.59
    Effective Tax Rate (%) 55.55
    Particulars MAR 2023 (Values in Cr)
    Revenue 46.78
    Operating Expense 50.03
    Net Profit -1.67
    Net Profit Margin (%) -3.56
    Earnings Per Share (EPS) -2.25
    EBITDA -1.81
    Effective Tax Rate (%) 42.21
    Particulars MAR 2022 (Values in Cr)
    Revenue 40.13
    Operating Expense 39.69
    Net Profit 0.87
    Net Profit Margin (%) 2.16
    Earnings Per Share (EPS) 1.18
    EBITDA 1.43
    Effective Tax Rate (%) -17.33
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 12.49
    ROE % 28.46
    ROCE % 27.03
    Total Debt to Total Equity 0.14
    EBITDA Margin 8.51
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 8.26
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.35
    EBITDA Margin 8.37
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 9.58
    ROE % 2.96
    ROCE % 7.17
    Total Debt to Total Equity 0.80
    EBITDA Margin 3.31
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 9.25
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.91
    EBITDA Margin -3.87
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 11.50
    ROE % 10.24
    ROCE % 6.74
    Total Debt to Total Equity 0.70
    EBITDA Margin 3.54
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 2.85
    Total Assets 24.55
    Total Liabilities 24.55
    Total Equity 9.72
    Share Outstanding 0
    Price to Book Ratio 2.47
    Return on Assets (%) 8.96
    Return on Capital (%) 19.97
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.77
    Total Assets 22.82
    Total Liabilities 22.82
    Total Equity 6.47
    Share Outstanding 0
    Price to Book Ratio 7.40
    Return on Assets (%) -4.28
    Return on Capital (%) -13.19
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 23.27
    Total Liabilities 23.27
    Total Equity 7.10
    Share Outstanding 0
    Price to Book Ratio 5.53
    Return on Assets (%) 1.04
    Return on Capital (%) 2.22
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.02
    Total Assets 28.52
    Total Liabilities 28.52
    Total Equity 6.86
    Share Outstanding 0
    Price to Book Ratio 1.80
    Return on Assets (%) -5.85
    Return on Capital (%) -11.83
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.50
    Total Assets 27.39
    Total Liabilities 27.39
    Total Equity 8.53
    Share Outstanding 0
    Price to Book Ratio 2.27
    Return on Assets (%) 3.18
    Return on Capital (%) 5.74
    Particulars MAR 2026 (Values in Cr)
    Net Income 3.03
    Cash from Operations 1.71
    Cash from Investing -0.10
    Cash from Financing 0.47
    Net change in Cash 2.08
    Free Cash Flow 1.74
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.39
    Cash from Operations 3.14
    Cash from Investing 0.45
    Cash from Financing -2.82
    Net change in Cash 0.68
    Free Cash Flow 3.14
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.54
    Cash from Operations 2.59
    Cash from Investing -0.45
    Cash from Financing -4.08
    Net change in Cash -1.93
    Free Cash Flow 2.67
    Particulars MAR 2023 (Values in Cr)
    Net Income -2.89
    Cash from Operations 0.06
    Cash from Investing 0.61
    Cash from Financing -0.12
    Net change in Cash 0.52
    Free Cash Flow 0.12
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.74
    Cash from Operations -0.34
    Cash from Investing -0.86
    Cash from Financing 1.53
    Net change in Cash 0.22
    Free Cash Flow 1.77
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 17.88 2.08 330.29 23.12 45.50
    BLISS GVS PHARMA LTD. 505.05 40.66 4.49 5365.85 118.35 552.90
    CIPLA LTD 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.65 25.80 3.99 1623.56 256.40 564.50
    GLAXOSMITHKLINE PHARMACEUTICAL 2566.55 41.30 19.17 43478.91 2088.00 2899.90
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 30.14 5.55 330.29 23.12 45.50
    AMRUTAJAN HEALTH LTD 525.20 23.54 4.10 1518.39 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8091.60 105.74 23.17 20229.00 7630.00 9850.00
    BLISS GVS PHARMA LTD. 505.05 54.66 4.64 5365.85 118.35 552.90

    GUJARAT TERCE LABORATORIES LTD shareholding pattern

    Holding
    59.97%
    40.02%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    GUJARAT TERCE LABORATORIES LTD Technicals Summary

    41.05 -2.14 redarrow
    red-green-graph indicator
    1 Bearish
    15 Bullish
    • 5 Days 40.00
    • 26 Days 36.30
    • 10 Days 38.30
    • 50 Days 35.80
    • 12 Days 37.90
    • 100 Days 36.60
    • 20 Days 36.70
    • 200 Days 40.20
    41.57 PIVOT
    First Support 40.13 First Resistance 43.38 Second Support 38.32 Second Resistance 44.82 Third Support 36.88 Third Resistance 46.63
    RSI 68.34 ADX 17.73 MACD 1.55 Williams % R -9.84 Commodity Channel Index (CCI) 191.43
    Date 2026-08-05 Week 9084.00 Same Day 4698.00 Month 4065.00
    1 Year 0.66 3 Year 0.27
    Over 1 Month
    23.41% down
    Over 1 Year
    -12.78% down
    Over 3 Months
    14.49% down
    Over 3 Years
    20.44% down
    Over 6 Months
    -1.54% down
    Over 5 Years
    21.29% down

    GUJARAT TERCE LABORATORIES LTD Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Gujarat Terce Laboratories Ltd?

    Answer Field

    Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 41.05 as on Aug 06 2026 03:29 PM.

    What is the Market Cap of Gujarat Terce Laboratories Ltd Share?

    Answer Field

    The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 32.00 as on Aug 06 2026 03:29 PM.

    What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

    Answer Field

    The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 59.78 and ₹ 29.00.

    What is 1 year return for Gujarat Terce Laboratories Ltd?

    Answer Field

    The 1 year returns on the stock has been -12.78%.

    What is the P/E Ratio of Gujarat Terce Laboratories Ltd Share?

    Answer Field

    As on Aug 06 2026 03:29 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is 14.82.

    What is the PB ratio of Gujarat Terce Laboratories Ltd Share?

    Answer Field

    As on Aug 06 2026 03:29 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 12.48.

    How to Buy Gujarat Terce Laboratories Ltd Share?

    Answer Field

    You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Gujarat Terce Laboratories Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Gujarat Terce Laboratories Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |